Risks and benefits for use of dolutegravir-based antiretroviral drug regimens in sub Saharan Africa: a modelling study

Phillips, Andrew, Venter, Francois, Havlir, Diana et al. (21 more authors) (2018) Risks and benefits for use of dolutegravir-based antiretroviral drug regimens in sub Saharan Africa: a modelling study. The Lancet HIV. pp. 1-12. ISSN 2405-4704

Metadata

Authors/Creators:
  • Phillips, Andrew
  • Venter, Francois
  • Havlir, Diana
  • Pozniak, Anton
  • Kuritzkes, Daniel
  • Wensing, Annemarie
  • Lundgren, Jens
  • De Luca, Andrea
  • Pillay, Deenan
  • Mellors, John
  • Cambiano, Valentina
  • Bansi-Matharu, Loveleen
  • Nakagawa, Fumiyo
  • Kalua, Thokozani
  • Jahn, Andreas
  • Apollo, Tsitsi
  • Mugurungi, Owen
  • Clayden, Polly
  • Gupta, Ravinda
  • Barnabas, Ruanne
  • Revill, Paul https://orcid.org/0000-0001-8632-0600
  • Cohn, Jennifer
  • Bertagnolio, Silvia
  • Calmy, Alexandra
Copyright, Publisher and Additional Information: © 2018 The Author(s). Published by Elsevier Ltd.
Dates:
  • Published: 2018
  • Published (online): 29 November 2018
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
Depositing User: Pure (York)
Date Deposited: 10 Dec 2018 15:10
Last Modified: 28 Jul 2020 23:24
Published Version: https://doi.org/10.1016/S2352-3018(18)30317-5
Status: Published online
Refereed: Yes
Identification Number: https://doi.org/10.1016/S2352-3018(18)30317-5

Downloads

Filename: regimen_ms_final_accepted_lancet_hiv_7_nov_2018.docx

Description: regimen ms - final accepted lancet hiv - 7 nov 2018

Licence: CC-BY-NC-ND 2.5

Filename: 1_s2.0_S2352301818303175_main.pdf

Description: 1-s2.0-S2352301818303175-main

Licence: CC-BY-NC-ND 2.5

Share / Export

Statistics